DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

Phase 4 Completed 40 enrolled Patrick R. Oellers, MD Ocular Therapeutix, Inc. · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate efficacy and safety of Dextenza for the treatment of postoperative pain and inflammation following vitreo-retinal surgery

Timeline

Start: 2020-01-03
Primary completion: 2022-03-31
Completion: 2022-03-31

Publications

Ueberroth JA, Oellers PR, Brown J, Rosenberg KI, Breazzano MP. Intracanalicular Dexamethasome Insert after Retinal Surgery: the ADHERE Trial. Ophthalmol Retina. 2023 Sep;7(9):831-833. doi: 10.1016/j.oret.2023.06.011. Epub 2023 Jun 24. No abstract available.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	0.4 mg	Other
Comparator	Prednisolone	Other / unclassified	—	Topical

Indications

No indication recorded.